Estrogens Promote Misfolded Proinsulin Degradation to Protect Insulin Production and Delay Diabetes
Open Access
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 24 (1) , 181-196
Abstract
No abstract availableKeywords
Funding Information
- Pfizer (DK099625, DK48280, 1 U54 GM104940, WS2069876)
- National Institutes of Health (DK107444, DK074970)
- U.S. Department of Veterans Affairs (BX003725)
This publication has 57 references indexed in Scilit:
- Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetesDiabetologia, 2012
- Endoplasmic Reticulum Stress and Type 2 DiabetesAnnual Review of Biochemistry, 2012
- Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic ReticulumScience, 2011
- SEL1L Protein Critically Determines the Stability of the HRD1-SEL1L Endoplasmic Reticulum-associated Degradation (ERAD) Complex to Optimize the Degradation Kinetics of ERAD SubstratesJournal of Biological Chemistry, 2011
- HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradationProceedings of the National Academy of Sciences, 2011
- The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancerCurrent Opinion in Pharmacology, 2010
- Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youthTrends in Endocrinology & Metabolism, 2010
- Extranuclear estrogen receptor-α stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesisProceedings of the National Academy of Sciences, 2010
- Developmental Phenotype of a Membrane Only Estrogen Receptor α (MOER) MouseJournal of Biological Chemistry, 2009
- Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in miceProceedings of the National Academy of Sciences, 2006